Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | P11 - Poster Session 11

Wednesday 04/29/20
08:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Pain, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG)
0.00 credit
Event Timeline
08:00 AM - 09:00 AM Abstract 9-001 - Menarche and Relapses in Girls with Pediatric Multiple Sclerosis
Kristen M. Krysko, MD
08:00 AM - 09:00 AM Abstract 9-002 - The Clinical Spectrum of Non-Traumatic Myelopathies in Childhood: 10 Years’ experience at a specialized center
Maria A. Garcia-Dominguez, MD
08:00 AM - 09:00 AM Abstract 9-003 - A Retrospective Chart Review of the Safety and Tolerability in Ocrelizumab in Pediatric and Young-Adult Onset Multiple Sclerosis
Carolyn Goldschmidt, DO
08:00 AM - 09:00 AM Abstract 9-004 - Pregnancy of MS patients treated with cladribine tablets
Kerstin Hellwig
08:00 AM - 09:00 AM Abstract 9-005 - Effects of Disease Modifying Therapy (DMT) Exposure on infant birth weight and birth length: Interim Data from Prospective PREG-MS Cohort.
Maria K. Houtchens, MD
08:00 AM - 09:00 AM Abstract 9-006 - A new activation assay reveals abnormal myelin and EBV antigen-reactivities superimposed on abnormal ‘autoactivation’ in pediatric multiple sclerosis
Ina Mexhitaj, PhD
08:00 AM - 09:00 AM Abstract 9-007 - Paediatric Primary Progressive Multiple Sclerosis: fact or fiction?
Yael Hacohen, MBBS
08:00 AM - 09:00 AM Abstract 9-008 - Pregnancy and obstetrical outcomes in women with RRMS
Tejas Sakale
08:00 AM - 09:00 AM Abstract 9-009 - Rituximab and Pregnancy in Neuroimmunological Disorders: A Retrospective Study
08:00 AM - 09:00 AM Abstract 9-010 - Gender Identity and Sexual Orientation Affect Healthcare Satisfaction, but not Utilization, in Persons with Multiple Sclerosis
Shahin Khayambashi, MD
08:00 AM - 09:00 AM Abstract 9-011 - Differences by Sex in the Workup of Children at High Risk for Multiple Sclerosis
Naila Makhani, MD
08:00 AM - 09:00 AM Abstract 9-012 - Anterior and Posterior Visual Pathway Injury in Pediatric-Onset Multiple Sclerosis as Measured by Visual Evoked Potentials and Magnetoencephalography
John R. Sollee
08:00 AM - 09:00 AM Abstract 9-013 - Prevalence of Serious Adverse Pregnancy Outcomes After Exposure to Interferon Beta Before or During Pregnancy: Stratification by Characteristics of Pregnant Women with MS in a Register-based Cohort study in Finland and Sweden
Jan A. Hillert, MD
08:00 AM - 09:00 AM Abstract 9-014 - An International Registry Tracking Pregnancy Outcomes in Women Treated with Dimethyl Fumarate
Kerstin Hellwig
08:00 AM - 09:00 AM Abstract 9-015 - Film as a Health Communication Tool in Hispanics to Understand Perceptions and Attitudes in Multiple Sclerosis
Lilyana M. Amezcua, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 9-016 - Revealing the Immune Cell Subtype Reconstitution Profile in Cladribine Treated Patients at the 96 Week Timepoint (CLARITY) Using Deconvolution Algorithms
08:00 AM - 09:00 AM Abstract 9-017 - Hypertension is Undertreated in Patients with Multiple Sclerosis
08:00 AM - 09:00 AM Abstract 9-019 - Therapeutic status quo in multiple sclerosis: a sign of hopelessness?
Gustavo Saposnik, MD
08:00 AM - 09:00 AM Abstract 9-020 - Postpartum Relapse After First On-Study Pregnancy in RRMS Patients Treated With Alemtuzumab in the Phase 2 and 3 Clinical Development Program Over 8 Years
Elisabeth G. Celius, MD
08:00 AM - 09:00 AM Abstract 9-021 - Effect of MS Disease Modifying Treatment Prices on the Day-to-Day Lives of People with MS
Bari Talente
08:00 AM - 09:00 AM Abstract 15-001 - Longitudinal Changes in Driving Behavior Following Antibody-Mediated Encephalitis
Gregory S. Day, MD, MSc, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 15-002 - Electroencephalographic (EEG) Findings in N-Methyl-D-Aspartase (NMDA) Encephalitis
Dustin M. Anderson, MD
08:00 AM - 09:00 AM Abstract 15-003 - Autoimmune Dementia – A Prospective Hospital-Based Study From A Tertiary Care Center In North India
Suman Kushwaha, MD
08:00 AM - 09:00 AM Abstract 15-004 - DPPX autoimmune encephalitis presenting with chronic diarrhea, multidirectional nystagmus, opsoclonus and prominent hyperekplexia
Karissa Arca, MD
08:00 AM - 09:00 AM Abstract 15-005 - A challenging case of rapidly progressive dementia: cryptococcal meningitis patient with co-existing positive anti-NMDA receptor antibody in CSF
Kyle M. Hodges
08:00 AM - 09:00 AM Abstract 15-006 - Generalised Epileptiform Activity in Anti-Glycine Receptor Antibody Autoimmune Limbic Encephalitis
Reuben Beer, MBBS
08:00 AM - 09:00 AM Abstract 15-007 - Zic4 Antibody Positive Autoimmune Encephalitis Responding to Rituximab After Failing First Line Therapies: A Case Report
Mays Alani, MD
08:00 AM - 09:00 AM Abstract 15-008 - Autoantibody Prevalence in Cerebrospinal Fluid in Autoimmune Encephalitis and Related Disorders: The Need for a More Targeted Screening Approach
Thomas R. Haven, PhD
08:00 AM - 09:00 AM Abstract 15-009 - Antibody screening using a tissue-based assay facilitates prompt induction of immunotherapy for autoimmune encephalitis
Makoto Hara, MD
08:00 AM - 09:00 AM Abstract 15-010 - Integration of an Evidence-Based Algorithm for Inpatient Autoimmune and Paraneoplastic Neurologic Syndrome Autoantibody Panel Ordering Practice to Improve Diagnostic Evaluation Quality
Anita M. Fletcher, MD
08:00 AM - 09:00 AM Abstract 15-011 - Endophenotypes of Non-Paraneoplastic Limbic Encephalitis in Childhood and Possible Underlying Immune Deficiencies/Dysregulations: A Case Series and Literature Review
Abdulla Alawadhi, MBBS
08:00 AM - 09:00 AM Abstract 15-012 - Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Resulting in Treatment-refractory Flaccid Paralysis
Juan Pablo Pauta Martinez, MD
08:00 AM - 09:00 AM Abstract 3-001 - Detecting Bradykinesia in Early Morning Off: A Large Database Study using the Personal KinetiGraph® (PKG®)
Stuart H. Isaacson, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 3-002 - Objective Markers of Finger Tapping in Idiopathic Parkinson’s Disease with Freezing of Gait
Hafsa Bareen Syeda, MBBS
08:00 AM - 09:00 AM Abstract 3-003 - Motion analysis of the pendulum test to assess rigidity in people with Parkinson’s disease
Giovanni Martino, PhD
08:00 AM - 09:00 AM Abstract 3-004 - Qualitative and quantitative measurement of skin surface fatty acids in Parkinson’s disease-the results of the first case-control study in any neurological condition.
Diana Angelika Olszewska, MD, PhD
08:00 AM - 09:00 AM Abstract 3-005 - Parkinson’s disease Significantly Increases Variability of Day-to-Day activity patterns
Danish Bhatti, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 3-006 - Impact of Medical Â鶹´«Ã½Ó³»­ on Knowledge of OFF-symptom Recognition and On-Demand Treatment Options Among Neurologists
Thomas Finnegan, Jr., PhD
08:00 AM - 09:00 AM Abstract 3-007 - Development of a Multivariable Proxy Model for Six-Minute Walk Distance (6MWD) in Duchenne Muscular Dystrophy (DMD) Using Machine Learning Methods
Nicolae Done, PhD
08:00 AM - 09:00 AM Abstract 3-008 - Cognitive loading during walking increases stride-to-stride randomness in people with Parkinson’s disease
08:00 AM - 09:00 AM Abstract 3-009 - Objective Markers of Foot Tapping in Idiopathic Parkinson’s Disease with Freezing of Gait
Aliyah J. Glover
08:00 AM - 09:00 AM Abstract 3-010 - Effect of Dopaminergic Medication on Adenosine 2A Receptor Availability in Patients with Parkinson’s Disease
Imran A. Waggan
08:00 AM - 09:00 AM Abstract 3-011 - Clinical Characteristics of Patients with Parkinson’s Disease and Cognitive Impairment
08:00 AM - 09:00 AM Abstract 3-012 - The UCSD Performance-based Skills Assessment Primarily Measures Attention, Executive Function, and Memory in Parkinson’s Disease
Samantha K. Holden, MD, MS, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 3-013 - Intrinsic Brain Functional Network Dynamics in Parkinson´s Disease Patients with Depression
08:00 AM - 09:00 AM Abstract 3-014 - Are Cognitive Deficits in Parkinson’s Disease Associated with Dopaminergic Dysfunction: A Graph Theory Analysis
Alexander Mihaescu
08:00 AM - 09:00 AM Abstract 3-015 - Gender Disparities in Treatment of Dysautonomia in Parkinson's Disease
Cameron C. Miller-Patterson, MD
08:00 AM - 09:00 AM Abstract 3-016 - The Effects of Medication and Parkinson’s Disease Severity on Proprioceptively Encoded Memory Guided Reaching
08:00 AM - 09:00 AM Abstract 3-017 - Blepharoclonus in Parkinson’s Disease: a prevalent and meaningful finding?
Jason H. Margolesky, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 12-001 - Attitudes Towards the Pharmacy Switch of Anti-epileptic Medications: Patient’s Perspective
Halina Sienkiewicz-Jarosz, PhD
08:00 AM - 09:00 AM Abstract 12-002 - Evaluating the implementation of a pharmacist-driven epilepsy education and adherence program
Magdalena M. Siodlak, Jr., PharmD
08:00 AM - 09:00 AM Abstract 12-003 - Safety, Tolerability, and Pharmacokinetics of ET-105, Lamotrigine for Oral Suspension, Under Fasting and Fed Conditions
08:00 AM - 09:00 AM Abstract 12-004 - Administration of Lamotrigine Formulation for Oral Suspension (ET-105) Through Gastrostomy Feeding Tubes
08:00 AM - 09:00 AM Abstract 12-005 - Time to Onset of Cannabidiol (CBD) Treatment Effect and Resolution of Adverse Events (AEs) in the Tuberous Sclerosis Complex (TSC) Phase 3 Randomized Controlled Trial (GWPCARE6)
Joyce Y. Wu, MD
08:00 AM - 09:00 AM Abstract 12-006 - Quality of Life and Qualitative Caregiver Assessments in Children and Adolescents with Developmental and Epileptic Encephalopathies Treated with Cannabidiol Transdermal Gel: An Open-label Clinical Trial
08:00 AM - 09:00 AM Abstract 12-007 - Cannabidiol Transdermal Gel in Children and Adolescents with Developmental and Epileptic Encephalopathies: An Open-label Clinical Trial
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO
08:00 AM - 09:00 AM Abstract 12-008 - A Review of the Pharmacokinetic Properties of Cenobamate (YKP3089), a Novel Antiepileptic Drug for the Treatment of Uncontrolled Focal Seizures in Adults
Stephen Greene
08:00 AM - 09:00 AM Abstract 12-009 - Cenobamate Adverse Events by Time of Onset and Dose From Two Randomized Clinical Studies in Patients With Uncontrolled Focal Seizures
Louis Ferrari
08:00 AM - 09:00 AM Abstract 12-010 - Efficacy of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures Based on Number of Concomitant Antiepileptic Drugs, Seizure Frequency, and Epilepsy Duration at Baseline
William E. Rosenfeld, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 12-011 - Safety of Cenobamate for the Treatment of Focal Seizures, Following 1-Week vs 2-Week Titration Schedules
Marc Kamin, MD
08:00 AM - 09:00 AM Abstract 12-012 - Population Pharmacokinetics Of Levetiracetam In Mexican Adult Patients With Epilepsy
Maria Patricia Hernández Mitre, PhD
08:00 AM - 09:00 AM Abstract 6-001 - Does Early Initiation of Palliative Care (PC) Consult of Neurocritical Care Patients Provide Added Value?
08:00 AM - 09:00 AM Abstract 6-002 - Non-Invasive Neuromodulation in Diabetic Peripheral Neuropathy: a meta-analysis
Kevin Pacheco-Barrios, MD
08:00 AM - 09:00 AM Abstract 6-003 - 10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial
Erika Petersen, MD
08:00 AM - 09:00 AM Abstract 6-005 - ALS Patient and Caregiver Attitudes toward Physician-Assisted Death in California
Anna Hauswirth, MD, PhD
08:00 AM - 09:00 AM Abstract 6-007 - A Palliative Care Â鶹´«Ã½Ó³»­ Needs Assessment Survey of Neurology Residents
Tara Cook, MD
08:00 AM - 09:00 AM Abstract 6-008 - Subcutaneous Tanezumab Versus Tramadol for Chronic Low Back Pain: Efficacy and Safety Results from a 56-Week Phase 3 Study with a 24-Week Follow Up Period
John Markman, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 6-010 - Online Case Challenges Demonstrate the Need for Continued Â鶹´«Ã½Ó³»­ Relating to the Assessment and Management of Chronic Pain Among Neurologists
08:00 AM - 09:00 AM Abstract 6-011 - Diagnostic pudendal nerve blocks followed by Pulsed Radiofrequency treatments in refractory chronic pelvic pain: A case series
Saugat Dey, MD
08:00 AM - 09:00 AM Abstract 6-012 - Medical Cannabis in the Treatment of Neuropathy
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 7-001 - Changes in Acute Migraine-specific Medications After Initiating Erenumab: Results from a Real-world Retrospective Cohort Study in the United States
08:00 AM - 09:00 AM Abstract 7-002 - Migraine: Another Health Disparity in Canada
08:00 AM - 09:00 AM Abstract 7-004 - The Accuracy of the Diagnosis of Migraines and Prevalence of Prophylactic Care Prescribed
Joseph Sisti IV
08:00 AM - 09:00 AM Abstract 7-005 - Psychiatric Burden of Patients with Syncope and Migraine
Marissa Sakoda, MD
08:00 AM - 09:00 AM Abstract 7-006 - First insights in real-world effectiveness of erenumab in chronic migraine patients with high burden of disease in Germany from the NTD headache and migraine registry
Stefan Braune
08:00 AM - 09:00 AM Abstract 7-007 - The Role of Insomnia in Migraine and Tension-type Headaches: A Population-Based Study
Jiyoung Kim
08:00 AM - 09:00 AM Abstract 7-008 - A Multidisciplinary Approach to Psychiatric Comorbidities in a Military Migraine Population
Virginia Baker, MD
08:00 AM - 09:00 AM Abstract 7-009 - Migraine and Functional Impairment Associated with Driving: Results of the OVERCOME Study
Richard B. Lipton, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 7-010 - I-BEAM: Impact and Burden of Episodic Acute Migraine – A Patient Experience Study
Stephen B. Shrewsbury, MD
08:00 AM - 09:00 AM Abstract 7-011 - Acute Treatment Management Gaps in People With Migraine: Results of the CaMEO Study
Dawn C. Buse, PhD
08:00 AM - 09:00 AM Abstract 7-012 - The Utility of the ID Migraine in Migraine Diagnosis in Calabar, Nigeria
Sidney Oparah, MD
08:00 AM - 09:00 AM Abstract 1-001 - A Novel Missense Mutation In The MYH7 Gene Causes An Uncharacteristic Phenotype Of Myosin Storage Myopathy: A Case Report
Alier Marrero, MD
08:00 AM - 09:00 AM Abstract 1-002 - A Novel Missense Mutation Causing Fascioscapulohumeral Dystrophy Type 2: A Case Report
Ali Ebrahim, MD
08:00 AM - 09:00 AM Abstract 1-004 - Genotype-Phenotype Variability in MTM1 Myopathy
Divya R. Shah, MBBS
08:00 AM - 09:00 AM Abstract 1-005 - A New Congenital Multicores Titinopathy with Myosin deficiency
Edoardo Malfatti, MD
08:00 AM - 09:00 AM Abstract 1-006 - Hypokalemic Periodic Paralysis: Clinical and Genetic Spectrum of a Pediatric Cohort
Alicia Henriquez, MD
08:00 AM - 09:00 AM Abstract 1-007 - Unusual Presentation of a Dystrophinopathy
Chaitanya Amrutkar, MD
08:00 AM - 09:00 AM Abstract 1-008 - Studying Clinical and Genetic Characteristics of Emery-Dreifuss Muscular Dystrophy
Gulshan Yunisova, MD
08:00 AM - 09:00 AM Abstract 1-009 - Novel Pathogenic Variant in the SCN10A Gene Associated with Autosomal Dominant Small Fiber Neuropathy.
Swathy Chandrashekhar, MD
08:00 AM - 09:00 AM Abstract 1-010 - Tissue Response to Change in Oxygen Conditions: Potential Role in Chemotherapy Induced Peripheral Neuropathy
08:00 AM - 09:00 AM Abstract 1-011 - Pyridoxine-Containing Nutritional or “Natural” Supplements: A Potential Cause of Worsening Neuropathy Symptoms
Miguel A. Santiago-Cruz
08:00 AM - 09:00 AM Abstract 1-012 - Daratumumab as First Line Therapy in a POEMS Syndrome Patient Demonstrating Atypical Features
Bo C. Leung, MD
08:00 AM - 09:00 AM Abstract 1-013 - Intermittent Acute Porphyria as a Differential Diagnosis of Peripheral Neuropathy: a Case Report Series
Karina L. Pires, MD
08:00 AM - 09:00 AM Abstract 1-014 - Focal leg weakness and sensory loss in a patient with neuroendocrine carcinoma of the lung
Eliz H. Agopian, MD
08:00 AM - 09:00 AM Abstract 1-015 - Chemotherapy-Induced Peripheral Neuropathy in Young Adults Treated with Vinca-Alkaloids
08:00 AM - 09:00 AM Abstract 10-001 - Comparing frequency of vascular risk factors in dementia with Lewy bodies and Alzheimer’s disease: A meta-analysis of observational cohort studies
Yinka Read, PsyD
08:00 AM - 09:00 AM Abstract 10-002 - Long-term Exposure to Air Pollution and the Risk of Dementia: the Role of Cardiovascular Disease
08:00 AM - 09:00 AM Abstract 10-003 - Impact of Race, Ethnicity and White Matter Hyperintensity on Incident Mild Cognitive Impairment at One Year after Lacunar Stroke: a Secondary Analysis of the SPS-3 Trial
Cecilia Peterson
08:00 AM - 09:00 AM Abstract 10-004 - Mortality and stroke risk in patients with dementia treated with renin-angiotensin system (RAS) blocking drugs. A longitudinal nationwide cohort study from the Swedish Dementia Registry
08:00 AM - 09:00 AM Abstract 10-005 - Clinical Profiles of Arteriosclerosis and Alzheimer’s Disease at Mild Cognitive Impairment and Early Dementia in a National Neuropathology Cohort
Dixon Yang, MD
08:00 AM - 09:00 AM Abstract 10-006 - Behavioral Markers for Processing Speed Deficits in a Vascular Cognitive Impairment Cohort
08:00 AM - 09:00 AM Abstract 10-007 - Regional Reductions in the Frequency of Vascular Dementia Were Detected in the West Amongst Patients Included in the National Inpatient Sample Database from 2006-2014
Alexis N. Simpkins, MD, PhD, MSCR, FAHA, FANA, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 10-008 - Histopathological Staging of Salient Cerebrovascular Lesions Associated With Normal Aging
Caroline Dallaire-Théroux, MD, PhD
08:00 AM - 09:00 AM Abstract 10-009 - Relationship between motoric cognitive risk syndrome, cardiovascular risk factors and diseases, and incident cognitive impairment: Results from a population-based cohort study
Olivier Beauchet, MD, PhD
08:00 AM - 09:00 AM Abstract 10-010 - High prevalence of stroke but low prevalence of Vascular dementia in a memory clinic from South India
Ratnavalli Ellajosyula, MD, DM, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 4-001 - A Case Series: Acute ACA Stroke Presenting With Spasticity
Amy W. Laitinen, MD
08:00 AM - 09:00 AM Abstract 4-002 - Acute Onset of Internuclear Ophthalmoplegia, Upbeat Nystagmus, and Exotropia from Ponto-mesencephalic Infarction.
Steven C. Yang, DO
08:00 AM - 09:00 AM Abstract 4-003 - Loeys-Dietz Syndrome and Ischemic Stroke
Michael Nahhas, MD
08:00 AM - 09:00 AM Abstract 4-004 - Seizure heralding the onset of acute stroke: Experience from a tertiary care center in Qatar.
Maria Siddiqi, MD
08:00 AM - 09:00 AM Abstract 4-005 - The Twitching Trunk: Etiology and Treatment of Truncal Myoclonus
Faraze Niazi
08:00 AM - 09:00 AM Abstract 4-006 - Unraveling Moyamoya- a clinico-radio-etiological study from India
Shambaditya Das, Jr., MD, MBBS
08:00 AM - 09:00 AM Abstract 4-007 - Case report: Diagnosis of Occult Cancer in Acute Ischemic Stroke Using Positron Emission Tomography Combined with Computed Tomography
Bastien Rioux, MD
08:00 AM - 09:00 AM Abstract 4-008 - A 47 F with multiple sclerosis presented with left MCA acute ischemic stroke and NSTEMI due to atypical thrombotic thrombocytopenic purpura.
Ronak Patel, MBBS
08:00 AM - 09:00 AM Abstract 4-009 - An Unusual Cause of Septic Emboli
Mariel Davila Martinez, MD
08:00 AM - 09:00 AM Abstract 4-010 - CADASIL: a provable disorder, when diagnosed can dramatically change management.
Muhammad H. Jaffer, MD
08:00 AM - 09:00 AM Abstract 4-011 - Acute ischemic stroke as a result of paradoxical embolus in a patient with renal cell carcinoma, intravenous tumor thrombus extension, and patent foramen ovale
David Gritsch, MD, PhD
08:00 AM - 09:00 AM Abstract 4-012 - Chronic Lymphocytic inflammation with Pontine perivascular enhancement responsive to steroids (CLIPPERS): A unique pathology and stroke mimic
Aman Deep, MD
08:00 AM - 09:00 AM Abstract 4-013 - Isolated Infratentorial PRES; An Atypical Presentation of a Common Neurological Disorder.
Muhammad Waleed Zeb, MD, MBBS
08:00 AM - 09:00 AM Abstract 4-014 - Balint’s syndrome presenting as the initial sign of occult breast cancer. Updating the diagnostic paradigm with recommendations for effective further management
Nara Michaelson, MD
08:00 AM - 09:00 AM Abstract 4-015 - A Rare Case of Ischemic Strokes due to Sarcoidosis Related Cerebral Phlebitis
Sonia Kaur Singh, MD
08:00 AM - 09:00 AM Abstract 4-016 - Anarthria caused by a Lesion in the Quadrilateral Space of Pierre Marie
Rashid A. Ahmed, MD
08:00 AM - 09:00 AM Abstract 4-017 - Internal Carotid Artery Web as a Cause of Ischemic Stroke in a Young Adult: a Case Report
Emily R. Grodinsky, MD
08:00 AM - 09:00 AM Abstract 4-018 - Vanishing Beauty: A Case of a 59-Year-Old Woman with Iatrogenic Central Retinal Artery Occlusion After Cosmetic Facial Augmentation with Filler Injections
Joseph Conovaloff, MD
08:00 AM - 09:00 AM Abstract 4-019 - Acute Ischemic Stroke due to Vasospasm after Daily Vaping of Tetrahydrocannabinol: a Case Report
08:00 AM - 09:00 AM Abstract 4-020 - Simultaneous Subarachnoid Hemorrhage and Transient Global Amnesia Secondary to Reversible Cerebral Vasoconstriction Syndrome
Reuben Beer, MBBS
08:00 AM - 09:00 AM Abstract 4-021 - A Unique Mechanism of Acute Ischemic Stroke in a Patient Presenting with Pseudo-Pseudo Meigs’ Syndrome Secondary to Systemic Lupus Erythematous
Alok Patel, MD
08:00 AM - 09:00 AM Abstract 13-001 - The Effect of Sex Hormones on the Secretion of the Insulin Receptor in HIV Infection
Miguel A. Santiago-Cruz
08:00 AM - 09:00 AM Abstract 13-002 - Atypical Spectrum of JC Virus Infection Syndrome: Report of Three Cases
William Souza Martins Ferreira
08:00 AM - 09:00 AM Abstract 13-003 - Determining the Neurocognitive status and the Functional Ability of patients to screen for HIV-Associated Neurocognitive Disorder (HAND)
08:00 AM - 09:00 AM Abstract 13-004 - Cryptococcal Infection Presenting with Upper and Lower Motor Findings
Jessica Z. Lee
08:00 AM - 09:00 AM Abstract 13-005 - Tabes Dorsalis in an HIV-infected Patient: a Case Report
Caroline L. Medeiros, Jr., MD
08:00 AM - 09:00 AM Abstract 13-006 - Facial Diplegia with distal paresthesias as variant of Guillain Barré Syndrome after Chikungunya infection: two case reports
Viviane T. Carvalho, MD
08:00 AM - 09:00 AM Abstract 13-007 - Cytomegalovirus Infection – Not So (H)armless
Zara A. Togher, MB BCh BAO
08:00 AM - 09:00 AM Abstract 13-008 - A pediatric case of Coxsackie A virus rhombencephalitis
Neel Fotedar, MD
08:00 AM - 09:00 AM Abstract 13-009 - The Role of Extracellular Vesicles (EVs) and EV-cargo in virally-mediated CNS diseases.
Setty M. Magana, MD, PhD
08:00 AM - 09:00 AM Abstract 13-010 - Heading West: An Uncommon Neurologic Presentation of West Nile Virus
Bianca Barcelo, MD
08:00 AM - 09:00 AM Abstract 13-011 - Idiopathic Spinal Epidural Abscess with Few Risk Factors causing Lumbosacral Radiculopathy
Michael A. Connerney, MD
08:00 AM - 09:00 AM Abstract 13-012 - Streptococcus Constellatus and Actinomyces Brain Abscess Without Signs of Contiguous Spread: A Case Report
Rahim Shakoor, MD
08:00 AM - 09:00 AM Abstract 13-013 - Influenza Associated Acute Hemorrhagic Leukoencephalopathy with Favorable Response to Treatment
Micah D. Yost, DO
08:00 AM - 09:00 AM Abstract 13-014 - Self Limiting Multiple Craniopathies secondary to Dengue Infection: A Case Report
Kimberly Geronimo
08:00 AM - 09:00 AM Abstract 13-015 - Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis
Pria Anand, MD
08:00 AM - 09:00 AM Abstract 13-016 - Medical Management of Intraventricular Neurocysticercosis
Karan Hingorani, MD, PhD
08:00 AM - 09:00 AM Abstract 13-017 - A Rare Case Of Fulminant Cerebral Phaeohyphomycosis In A Transplanted Patient.
Daniel Garbin Di Luca, MD
08:00 AM - 09:00 AM Abstract 13-018 - Rocky Mountain spotted fever presenting with meningoencephalitis and bilateral abducens nerve palsies
Melissa Ng, MB BChir
08:00 AM - 09:00 AM Abstract 5-001 - Resting State Functional Connectivity and White Matter Integrity as Biomarkers to Track Brain Changes in Former Athletes with Multiple Concussions
Anna Vasilevskaya, PhD
08:00 AM - 09:00 AM Abstract 5-002 - Sulcal Cavitation During Head Impact and Correlating with Mild Traumatic Brain Injury Neuropathology
Jacob L. Van Orman, MD
08:00 AM - 09:00 AM Abstract 5-003 - sLORETA Volumetric Quantitative EEG Analysis in High School Athletes Shortly After Sport Concussion Injury: Dysfunction and Compensation
Harry G. Kerasidis, MD
08:00 AM - 09:00 AM Abstract 5-004 - A Scoping Review of Registered Clinical Studies on Concussion and Mild Traumatic Brain Injury (2000-2019) Shows an Encouraging Diversity of Research Initiatives, but a Problematic Variability of Injury Definitions.
Julio C. Furlan, MD, PhD, MBA, MSc, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 5-005 - Effects of Aerobic Exercise Training on Carotid Arterial Stiffness and Brain Health in Traumatic Brain Injury
Tran B. Le, MD
08:00 AM - 09:00 AM Abstract 5-006 - Skilled Motor Task Improvement using Alternative Auditory Feedback
Robert J. Giombetti, MD
08:00 AM - 09:00 AM Abstract 5-007 - Cerebrovascular Reactivity: Subject-Level Classification Model for Acute Concussion.
08:00 AM - 09:00 AM Abstract 5-008 - Synthesis of Behavioral Health Outcomes in Mild Traumatic Brain Injury using Principal Component Analysis (PCA)
George Skulikidis, PA
08:00 AM - 09:00 AM Abstract 5-009 - Measurement of inflammatory cytokines and neurodegenerative/injury biomarkers in acute concussion/mild traumatic brain injury (c/mTBI) serum and saliva samples
Ahmed Chenna, PhD
08:00 AM - 09:00 AM Abstract 5-010 - Regional Variation in Sulfonylurea Receptor-1 Regulated Channel Expression after Repetitive Mild Traumatic Brain Injury in Mice: An Exploratory Study
Benjamin Zusman, MD
08:00 AM - 09:00 AM Abstract 5-011 - Balance and pain scores improve after occipital nerve blocks from cranio-cervical trauma.
Brittany L. Poinson, MD
08:00 AM - 09:00 AM Abstract 5-012 - Variations in Cause of Injury May Explain Disparities in In-Hospital Mortality after TBI
Sai P. Polineni, MD
08:00 AM - 09:00 AM Abstract 5-013 - Effect of Therapeutic Hypothermia on Outcomes After Severe Traumatic Brain Injury: A Nationwide Inpatient Sample analysis
Harathi Bandaru, MD
Faculty Disclosures
Soe S. Mar, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Mar has received research support from NIH.
Christina Wilson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH Stroke Net. The institution of an immediate family member of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Bristol-Myers Squibb and BMS-Pfizer/Roche Diagnostics . An immediate family member of Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care.
Adam De Havenon, MD, FÂ鶹´«Ã½Ó³»­ Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Ruth-Ann Marrie, MD, PhD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Tracey Cho, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Rima Dafer, MD Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.
Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FÂ鶹´«Ã½Ó³»­ Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hyperfine. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. The institution of Dr. Mechtler has received research support from Hyperfine. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Tamara B. Kaplan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono . Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Nicholas D. Osteraas, MD Dr. Osteraas has nothing to disclose.
Edoardo Malfatti, MD Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from ANR.
Angel P. Sempere, MD Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Richard J. Barohn, MD, FÂ鶹´«Ã½Ó³»­ Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Robert A. Hauser, MD, MBA, FÂ鶹´«Ã½Ó³»­ Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Gustavo Saposnik, MD Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Danish Bhatti, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bhatti has nothing to disclose.
Daniel Kremens, MD, JD, FÂ鶹´«Ã½Ó³»­ Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Neurocrine. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Kremens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerevel. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for UCB.
Marisara Dieppa, MD Dr. Dieppa has nothing to disclose.
Annie L. Hsieh, MD, PhD An immediate family member of Dr. Hsieh has received personal compensation for serving as an employee of Pfizer.
Stewart A. Factor, DO, FÂ鶹´«Ã½Ó³»­ Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Eric Pearlman, MD Dr. Pearlman has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Pearlman has received stock or an ownership interest from Eli Lilly and Co.
Marc Kamin, MD Dr. Kamin has received personal compensation for serving as an employee of SK LIFE SCIENCE INC.
Mrinal K. Acharya, MBBS No disclosure on file
Carlos A. Pardo-Villamizar, MD The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Alan J. Thompson, MD, FRCP, FÂ鶹´«Ã½Ó³»­ No disclosure on file
No disclosure on file
Stephen B. Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Unsong Oh, MD Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon Therapeutics. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Farhad Sahebkar-Moghaddam, MD Dr. Sahebkar-Moghaddam has received personal compensation for serving as an employee of Jazz pharmaceuticals. Dr. Sahebkar-Moghaddam has stock in Jazz pharmaceuticals.
Bart Demaerschalk, MD, MSc, FRCPC, FÂ鶹´«Ã½Ó³»­ Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
John A. Messenheimer, Jr., MD Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care.
Joe Hulihan, Jr., MD Dr. Hulihan has received personal compensation for serving as an employee of MARINUS PHARMACEUTICALS. Dr. Hulihan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ZYNERBA PHARMACEUTICALS.
Richard H. Swartz, BSc MD PhD FRCPC The institution of Dr. Swartz has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Swartz has received research support from Ontario Brain Institute.
Zara A. Togher, MB BCh BAO Dr. Togher has nothing to disclose.
Maria V. Diaz Rojas, MD Dr. Diaz Rojas has nothing to disclose.
Lakshmi Pillai Ms. Pillai has nothing to disclose.
Pria Anand, MD Dr. Anand has nothing to disclose.
Min Kyung Chu, MD, PhD No disclosure on file
Daniel Corcos, PhD Daniel Corcos, PhD has nothing to disclose.
Robert A. Nicholson, PhD Dr. Nicholson has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Nicholson has stock in Eli Lilly & Company. Dr. Nicholson has received intellectual property interests from a discovery or technology relating to health care.
Ugur Uygunoglu Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Eugene Shapiro No disclosure on file
Kimberly Geronimo No disclosure on file
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Felipe Fregni Felipe Fregni has nothing to disclose.
Robert I. Thompson-Stone, MD, FÂ鶹´«Ã½Ó³»­ Dr. Thompson-Stone has received personal compensation in the range of $500-$4,999 for serving as a Krabbe Disease expert with Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). Dr. Thompson-Stone has a non-compensated relationship as a Editorial Board Member with Neurology: Â鶹´«Ã½Ó³»­ Journal that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Artemio A. Roxas, Jr., MD Dr. Roxas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Philippines.
Rohini D. Samudralwar, MD Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Fabian H. Rossi, MD Dr. Rossi has nothing to disclose.
Christina Azevedo, MD, FÂ鶹´«Ã½Ó³»­ Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas Biopharma. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Smith, Henning & Berman LLP. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Shamik Bhattacharyya, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Starane A. Shepherd, MD Dr. Shepherd has nothing to disclose.
Maria K. Houtchens, MD Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech. The institution of Dr. Houtchens has received research support from Novartis.
Andrei V. Alexandrov, MD The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Thomas Leist, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Arman Sabet, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sabet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Sabet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Sabet has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for BOD Australia. Dr. Sabet has stock in CSL.
Kan Ding, MD The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Sutapa Ray, PhD Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Ali Ebrahim, MD Dr. Ebrahim has nothing to disclose.
Timothy Lynch, MD Dr. Lynch has nothing to disclose.
Megan M. Langille, MD Dr. Langille has nothing to disclose.
Ami Cuneo, MD Dr. Cuneo has nothing to disclose.
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Muhammad H. Jaffer, MD Dr. Jaffer has nothing to disclose.
David A. Shirilla, DO No disclosure on file
Jiyoung Kim No disclosure on file
Mamatha Pasnoor, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Salvador Cruz-Flores, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Olga Ciccarelli, MD, PhD, FRCP Prof. Ciccarelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Naim I. Haddad, MD, FÂ鶹´«Ã½Ó³»­ Dr. Haddad has nothing to disclose.
Devon Conway, MD Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Omar Jawdat, MD Dr. Jawdat has nothing to disclose.
Daniel P. Perl, MD No disclosure on file
Viviane T. Carvalho, MD Dr. Carvalho has nothing to disclose.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Anna Marisa Cervantes-Arslanian, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cervantes-Arslanian has nothing to disclose.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Naila Makhani, MD Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Institute for Advanced Clinical Trials for Children. The institution of Dr. Makhani has received research support from NIH/NINDS. The institution of Dr. Makhani has received research support from Charles H Hood Foundation. The institution of Dr. Makhani has received research support from National Multiple Sclerosis Society. Dr. Makhani has received personal compensation in the range of $0-$499 for serving as a contributor to online content with WebMD. Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a contributor to a CME video podcast and newsletter with eMultiple Sclerosis Review. Dr. Makhani has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with I-ACT for children.
Ruchira M. Jha, MD Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
James N. Brenton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Nara Michaelson, MD The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS). Dr. Michaelson has received research support from Sanofi.
Veronika Shabanova No disclosure on file
Jessica Frey, MD The institution of Dr. Frey has received research support from Tourette Association of America.
Gian D. Pal, MD Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm.
Wendy S. Vargas, MD Dr. Vargas has received personal compensation for serving as an employee of Sanofi.
Robert W. Charlson, MD Dr. Charlson has nothing to disclose.
Marissa Sakoda, MD No disclosure on file
Rinze F Neuteboom Rinze F Neuteboom has nothing to disclose.
Janice Vargas, MD Dr. Vargas has nothing to disclose.
Benjamin Zusman, MD Mr. Zusman has received research support from University of Pittsburgh .
Judith A. White, MD, PhD No disclosure on file
Jonathan L. Carter, MD Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Sakir H. Gultekin, MD No disclosure on file
Jeffrey D. Jirsch, MD No disclosure on file
Hermelinda Abcede, MD Dr. Abcede has nothing to disclose.
Cynthia Jones, PhD Dr. Jones has received personal compensation for serving as an employee of Biogen. Dr. Jones has received stock or an ownership interest from Biogen.
Mazen M. Dimachkie, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Â鶹´«Ã½Ó³»­ (Â鶹´«Ã½Ó³»­). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (Â鶹´«Ã½Ó³»­EM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Jun Li, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Osvaldo J. Nascimento, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nascimento has nothing to disclose.
Cheryl Hemingway Cheryl Hemingway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Cheryl Hemingway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Cheryl Hemingway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Constantine Farmakidis, MD, FÂ鶹´«Ã½Ó³»­ Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Laura C. Gioia, MD Dr. Gioia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier Inc.
Adam M. Willis, MD The institution of Dr. Willis has received research support from Air Force. Dr. Willis has received intellectual property interests from a discovery or technology relating to health care.
Kevin E. Crutchfield, MD Dr. Crutchfield has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ryan,Ryan and Deluca.
Yael Hacohen, MBBS Dr. Hacohen has nothing to disclose.
Orrin Devinsky, MD, FÂ鶹´«Ã½Ó³»­ Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Mark R. Keezer, MD, PhD The institution of Dr. Keezer has received research support from TD Bank. The institution of Dr. Keezer has received research support from Savoy Foundation. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research. The institution of Dr. Keezer has received research support from Fonds de Recherche Québec Santé. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research. The institution of Dr. Keezer has received research support from Precision Child Health Partnership Catalyst Program.
Per Soelberg Sorensen No disclosure on file
Alberto Maud, MD Dr. Maud has nothing to disclose.
Paisith Piriyawat, MD Dr. Piriyawat has nothing to disclose.
Ahmed Hassan, MD No disclosure on file
Hardik Amin, MD No disclosure on file
Ursula Boschert Shafaatian Ursula Boschert has nothing to disclose.
Caroline B. Braune, MD Dr. Braune has nothing to disclose.
Michael Hoffmann, MD, FCP, FAHA, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Eliza M. Gordon-Lipkin, MD No disclosure on file
Natalia Murinova, MD, FÂ鶹´«Ã½Ó³»­ Dr. Murinova has nothing to disclose.
Lana Zhovtis Ryerson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Fatma Yesim Parman, MD Dr. Parman has nothing to disclose.
John Winslow, PhD Dr. Winslow has received personal compensation for serving as an employee of Labcorp/Monogram Biosciences. Dr. Winslow has received personal compensation for serving as an employee of Labcorp/Monogram Biosciences. Dr. Winslow has stock in Labcorp. Dr. Winslow has received intellectual property interests from a discovery or technology relating to health care.
Mays Alani, MD No disclosure on file
Hu Li No disclosure on file
Philippe Cabre No disclosure on file
Richard B. Lipton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Francoise Durand Dubief The institution of Francoise Durand Dubief has received research support from ARSEP.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Patrick M. Kochanek, MD, MCCM Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Washington. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johns Hopkins Health System. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for de Boisblanc Law Firm. The institution of Patrick M. Kochanek, MD, MCCM has received research support from Chuck Noll Foundation. The institution of Patrick M. Kochanek, MD, MCCM has received research support from NIH. Patrick M. Kochanek, MD, MCCM has received publishing royalties from a publication relating to health care.
Guillaume Mathey Guillaume Mathey has nothing to disclose.
Sai P. Polineni, MD Dr. Polineni has nothing to disclose.
Monika Koerwer, MD No disclosure on file
Juha O. Rinne, MD, PhD No disclosure on file
Sona Narula, MD Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
Eero Rissanen, MD Dr. Rissanen has received research support from Sigrid Juselius Foundation.
Eric Thouvenot, MD, PhD Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Duaa Jabari, MD Dr. Jabari has nothing to disclose.
Niall Tubridy, MD Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Rakesh Khatri, MD, FÂ鶹´«Ã½Ó³»­ Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Julia O'Mahony Ms. O'Mahony has nothing to disclose.
Sean Connolly, MD, MRCPI Dr. Connolly has received publishing royalties from a publication relating to health care.
Munro Cullum, PhD The institution of Dr. Cullum has received research support from NIH. Dr. Cullum has received intellectual property interests from a discovery or technology relating to health care. Dr. Cullum has received personal compensation in the range of $10,000-$49,999 for serving as a Scientific Director with Texas Alzheimers Research and Care Consortium.
Colin M. Roberts, MD Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded.
David Gritsch, MD, PhD Dr. Gritsch has nothing to disclose.
Jean Pelletier, MD, PhD Dr. Pelletier has nothing to disclose.
Sunita Venkateswaran, MD Dr. Venkateswaran has nothing to disclose.
Nina Tsakadze, MD, PhD No disclosure on file
Tigran Kesayan, MD Dr. Kesayan has nothing to disclose.
Piraye Serdaroglu, MD No disclosure on file
Arnfin Bergmann Dr. Bergmann has nothing to disclose.
Teddy S. Youn, MD Dr. Youn has nothing to disclose.
Clarisse Carra-Dalliere No disclosure on file
Evangeline Wassmer, MD Dr. Wassmer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wassmer has received research support from Birmingham Children's Hospital Charity Research Foundation.
Sonia M. Caraballo-Cartagena, MD Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
Suman Kushwaha, MD Dr. Kushwaha has nothing to disclose.
Daniela Pohl Daniela Pohl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos.
Mukesh Kumar, MD No disclosure on file
Adam Kelly, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kelly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grand Rounds/Included Health. Dr. Kelly has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Kelly has received personal compensation in the range of $500-$4,999 for serving as a Question writer for various educational offerings with Â鶹´«Ã½Ó³»­.
Erin G. Doty, MD Dr. Doty has received personal compensation for serving as an employee of Eli Lilly and Company, USA. Dr. Doty has stock in Eli Lilly and Company, USA.
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Silvia Tenembaum, MD Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals Inc. .
Vikram Kamath, MD Dr. Kamath has nothing to disclose.
Laura Airas, MD, PhD Dr. Airas has nothing to disclose.
Ratnavalli Ellajosyula, MD, DM, FÂ鶹´«Ã½Ó³»­ Dr. Ellajosyula has nothing to disclose.
Allan McCarthy, MD Dr. McCarthy has nothing to disclose.
Alexis N. Simpkins, MD, PhD, MSCR, FAHA, FANA, FÂ鶹´«Ã½Ó³»­ Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institute of Neurological Disorders and Stroke Data Safety Monitoring Board. Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. The institution of Dr. Simpkins has received research support from NIH/NIA. The institution of Dr. Simpkins has received research support from Bristol-Meyer Squibb Foundation. The institution of Dr. Simpkins has received research support from Corxel. Dr. Simpkins has received publishing royalties from a publication relating to health care.
Nandakumar Nagaraja, MD The institution of Dr. Nagaraja has received research support from 1 Florida Alzheimer's Disease Research Center. Dr. Nagaraja has received personal compensation in the range of $500-$4,999 for serving as a stroke outcome adjudicator for WHI study with Fred Hutchinson Cancer Research Center.
Laura S. Munoz-Arcos, MD No disclosure on file
Gulshan Yunisova, MD Dr. Yunisova has nothing to disclose.
Martin A. Myers, MD No disclosure on file
Ilya Kister, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Darin T. Okuda, MD, FÂ鶹´«Ã½Ó³»­ Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Andrew Solomon, MD, FÂ鶹´«Ã½Ó³»­ Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
Charles E. Argoff, MD Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for XGene. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Colllegium. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Argoff has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Scilex. The institution of Dr. Argoff has received research support from Lilly. The institution of Dr. Argoff has received research support from Lundbeck. The institution of Dr. Argoff has received research support from Abbvie. The institution of Dr. Argoff has received research support from Vertex. Dr. Argoff has received publishing royalties from a publication relating to health care.
Kristen M. Krysko, MD Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Krysko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Krysko has received research support from MS Society of Canda. The institution of Dr. Krysko has received research support from Roche.
Samantha K. Holden, MD, MS, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Holden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics.
Teri Schreiner, MD, MPH, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Erik K. Henricson, MPH No disclosure on file
Gilles Allali, MD, PhD Dr. Allali has nothing to disclose.
Ellen S. Lathi, MD No disclosure on file
Mitesh P. Lotia, MD Dr. Lotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphalan. Dr. Lotia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott.
Alexander Mihaescu The institution of Mr. Mihaescu has received research support from Canadian Institutes of Health Research.
Mary R. Rensel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech . The institution of Dr. Rensel has received research support from Biogen.
Marian Gomez-Beldarrain, MD Dr. Gomez-Beldarrain has nothing to disclose.
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Alice Edwards, DO The institution of Dr. Rutatangwa has received research support from NIH.
Lana Chahine, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chahine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gray Matters Technology. The institution of Dr. Chahine has received research support from UPMC. The institution of Dr. Chahine has received research support from MJFF. The institution of Dr. Chahine has received research support from Denali/Biogen. Dr. Chahine has received publishing royalties from a publication relating to health care.
Biljana Beretich, MD No disclosure on file
Syed Rizvi, MD Dr. Rizvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono Roche Bristol Myers . Dr. Rizvi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Na.
Diana Castro, MD Dr. Castro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Castro has received research support from Biogen. The institution of Dr. Castro has received research support from Sarepta. The institution of Dr. Castro has received research support from Fibrogen .
Jeffrey M. Katz, MD Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Ursela Baber, MD No disclosure on file
Jessica H. Goldstein, MD, FÂ鶹´«Ã½Ó³»­ Dr. Goldstein has nothing to disclose.
Maria Chiara Monaco Maria Chiara Monaco has nothing to disclose.
Andres De Leon, MD Dr. De Leon has nothing to disclose.
Emily R. Grodinsky, MD No disclosure on file
Adriana Calosso, NP No disclosure on file
Alok Patel, MD No disclosure on file
Nicholas L. Zalewski, MD Dr. Zalewski has nothing to disclose.
Elena Pegoraro, MD, PhD No disclosure on file
Carlos Singer, MD Dr. Singer has nothing to disclose.
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Robert J. Fox, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Kevin M. Biglan, MD Dr. Biglan has received personal compensation for serving as an employee of Eli Lilly. Dr. Biglan has received stock or an ownership interest from Eli Lilly.
Ann Murray, MD Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Daniel Krashin, MD Dr. Krashin has nothing to disclose.
Shambaditya Das, Jr., MD, MBBS Dr. Das has nothing to disclose.
Siddharth Maheshwari, DM No disclosure on file
Vincent H. Bargnes III Mr. Bargnes has received research support from Harry Dent Family Foundation.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Eric Klawiter, MD, FÂ鶹´«Ã½Ó³»­ Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Lilyana M. Amezcua, MD, FÂ鶹´«Ã½Ó³»­ Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS. The institution of Dr. Amezcua has received research support from Sanofi/Genzyme. The institution of Dr. Amezcua has received research support from Alexion.
Dessa Sadovnick, PhD No disclosure on file
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Adrian Marchidann, MD Dr. Marchidann has stock in Eli Lilly. Dr. Marchidann has stock in Pfizer. Dr. Marchidann has stock in Merck. Dr. Marchidann has stock in Illumina. Dr. Marchidann has stock in Aeterna Zentaris. Dr. Marchidann has stock in Abbot. Dr. Marchidann has received publishing royalties from a publication relating to health care. Dr. Marchidann has received publishing royalties from a publication relating to health care.
Leslie A. Benson, MD The institution of Dr. Benson has received research support from ROHHAD Fight, Inc. The institution of Dr. Benson has received research support from NIH. The institution of Dr. Benson has received research support from Roche/Genentech. Dr. Benson has received personal compensation in the range of $0-$499 for serving as a consultant with MA Department of public health. Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as a consultant with National vaccine injury compensation program.
Jason H. Margolesky, MD, FÂ鶹´«Ã½Ó³»­ Dr. Margolesky has nothing to disclose.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
John W. Rose, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Brenda L. Banwell, MD, FÂ鶹´«Ã½Ó³»­ Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Lauren B. Krupp, MD, FÂ鶹´«Ã½Ó³»­ Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Emmanuelle Waubant, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Salvatore Napoli, MD Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for vaccine injury.
Gregory S. Aaen, MD Dr. Aaen has nothing to disclose.
Margaret E. Burnett, MD Dr. Burnett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prism. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Burnett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Burnett has received research support from Genentech.
Ivonne Vicente, MD Dr. Vicente has nothing to disclose.
Dorlan J. Kimbrough, MD Dr. Kimbrough has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CVS.
Dustin M. Anderson, MD No disclosure on file
Theron C. Casper, PhD Dr. Casper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aperta Biosciences. The institution of Dr. Casper has received research support from NIH. The institution of Dr. Casper has received research support from The National Multiple Sclerosis Society. The institution of Dr. Casper has received research support from Roche. The institution of Dr. Casper has received research support from Biogen. The institution of Dr. Casper has received research support from UCB.
Magdalena M. Siodlak, Jr., PharmD No disclosure on file
Harry G. Kerasidis, MD No disclosure on file
Lisa K. Peterson, PhD Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werfen. Dr. Peterson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Werfen. Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AliveDx. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Biochemistry. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lab Q for ASCP. Dr. Peterson has a non-compensated relationship as a President with Association of Medical Laboratory Immunologists that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Antonio Strafella, MD No disclosure on file
Timothy E. Lotze, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Nagagopal Venna, MBBS, FÂ鶹´«Ã½Ó³»­ Dr. Venna has nothing to disclose.
Tuhin Virmani, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Virmani has received research support from Parkinson's Foundation.
Claudia J. Chaves, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Karina L. Pires, MD Dr. Pires has nothing to disclose.
Foad Taghdiri, MD, MSc Dr. Taghdiri has nothing to disclose.
Inigo G. Cuellar Inigo Gabilondo Cuellar has nothing to disclose.
Stuart H. Isaacson, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Teena Shetty, MD, FÂ鶹´«Ã½Ó³»­ Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.
Elisabeth G. Celius, MD Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Celius has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Victoria Lawson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lawson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Alier Marrero, MD Dr. Marrero has nothing to disclose.
Eric J. Pappert, MD No disclosure on file
Rajesh Pahwa, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Virginia A. Devonshire, MD Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck- Serono. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen . Dr. Devonshire has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for novartis. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for roche. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biogen .
Danielle S. Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Luca Marinelli Luca Marinelli has received personal compensation for serving as an employee of General Electric.
Shahin Khayambashi, MD Dr. Khayambashi has nothing to disclose.
Hideto Nakajima, MD No disclosure on file
Kristina M. Fanning, PhD The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA.
Chirantan Banerjee, MD, MPH Dr. Banerjee has nothing to disclose.
Hartmut Uschmann, MD Dr. Uschmann has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Samson & Powers, PLLC.
Virginia Baker, MD Dr. Baker has nothing to disclose.
Lee Wilson No disclosure on file
Kyle M. Hodges No disclosure on file
Luis Felipe Haberfeld Maia, MD No disclosure on file
Julio C. Furlan, MD, PhD, MBA, MSc, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Furlan has received research support from Wings for Life Spinal Cord Research Foundation. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Ontario Neurotrauma Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from J P Bickell Foundation. The institution of Dr. Furlan has received research support from Praxis Spinal Cord Institute. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from CRANIA. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Tanenbaum Institute for Science in Sport. .
Rena Sukhdeo Singh, MD No disclosure on file
Abdulla Alawadhi, MBBS Dr. Alawadhi has nothing to disclose.
Sandra Thiel Ms. Thiel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer Healthcare .
Colin Mitchell, PhD No disclosure on file
Ekenedilichukwu C. Nwoye, MD No disclosure on file
Bianca Barcelo, MD No disclosure on file
Leanne Munsie Leanne Munsie has received personal compensation for serving as an employee of Eli Lilly and Company. Leanne Munsie has received stock or an ownership interest from Eli Lilly and Company.
Tejas Sakale No disclosure on file
Jayne Ness, MD An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
Christopher Severson, MD Dr. Severson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Severson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Idanis Berrios Morales, MD Dr. Berrios Morales has nothing to disclose.
Neel Fotedar, MD Dr. Fotedar has received research support from NINDS.
Cameron C. Miller-Patterson, MD Dr. Miller-Patterson has nothing to disclose.
Barry E. Gidal, PhD Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai . Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK life sciences . Dr. Gidal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK life science .
Susan T. Iannaccone, MD, FÂ鶹´«Ã½Ó³»­ Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. The institution of Dr. Iannaccone has received research support from AveXis. The institution of Dr. Iannaccone has received research support from Biogen. The institution of Dr. Iannaccone has received research support from Sarepta. The institution of Dr. Iannaccone has received research support from PTC Therapeutics. The institution of Dr. Iannaccone has received research support from FibroGen. The institution of Dr. Iannaccone has received research support from ReveraGen. The institution of Dr. Iannaccone has received research support from MDA. The institution of Dr. Iannaccone has received research support from PPMD. The institution of Dr. Iannaccone has received research support from NIH. Dr. Iannaccone has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Luis D. Medina, PhD The institution of Dr. Medina has received research support from National Institutes of Health. Dr. Medina has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AbbVie. Dr. Medina has a non-compensated relationship as a Council Member with Alzheimer's Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Steven Jacobson Steven Jacobson has nothing to disclose.
Dennis K. Burns, MD No disclosure on file
Divya R. Shah, MBBS Dr. Shah has nothing to disclose.
Craig McDonald, MD Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Angel R. Chinea, MD Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for novartis. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for emd serono. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for emd serono. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for allergan.
Kedar Mahajan, MD, PhD Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Mahajan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
Amy Lavery No disclosure on file
Ewa Krzystanek Ewa Krzystanek has nothing to disclose.
Swathy Chandrashekhar, MD Dr. Chandrashekhar has received publishing royalties from a publication relating to health care.
Michael V. Robers, MD Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation.
Carol F. Lippa, MD Dr. Lippa has nothing to disclose.
Diego Torres-Russotto, MD, FÂ鶹´«Ã½Ó³»­ Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
Tara Cook, MD No disclosure on file
Anat Achiron, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Achiron has nothing to disclose.
Carolina Ionete, MD Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Becky J. Parks, MD Dr. Parks has received personal compensation for serving as an employee of Alexion Pharmaceuticals. An immediate family member of Dr. Parks has received personal compensation for serving as an employee of Edward P. Evans Foundation. Dr. Parks has stock in Biogen. An immediate family member of Dr. Parks has stock in Regeneron. Dr. Parks has stock in Blueprint Medicines. Dr. Parks has stock in Sanofi. An immediate family member of Dr. Parks has stock in Vertex. Dr. Parks has stock in AstraZeneca. The institution of an immediate family member of Dr. Parks has received research support from NIH/NCI. The institution of an immediate family member of Dr. Parks has received research support from Leukemia & Lymphoma Society. The institution of an immediate family member of Dr. Parks has received research support from AstraZeneca Scholar Award.
Jacob L. McCauley No disclosure on file
Michael Sweeney, MD Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Tarun Singhal, MD Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme Sanofi. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana LifeSciences. The institution of Dr. Singhal has received research support from Novartis. The institution of Dr. Singhal has received research support from Department of Defense. The institution of Dr. Singhal has received research support from Foundation for Neurologic Diseases.
Carmela Tartaglia, MD Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Tartaglia has received research support from NIH. The institution of Dr. Tartaglia has received research support from University of Toronto.
Christopher McGuigan, MD An immediate family member of Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. McGuigan has received research support from Novartis.
Jesse Thon, MD An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Setty M. Magana, MD, PhD Dr. Magana has nothing to disclose.
James M. Stankiewicz, MD, FÂ鶹´«Ã½Ó³»­ Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
David Rog, MBBS Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Rog has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rog has received research support from Merck. The institution of Dr. Rog has received research support from Novartis. The institution of Dr. Rog has received research support from TG Therapeutics. Dr. Rog has received research support from Janssen-Cilag.
David J. Mikulis, MD Dr. Mikulis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neinstein Personal Injury Lawyers. Dr. Mikulis has received stock or an ownership interest from Thornhill Medical, Inc.. Dr. Mikulis has received intellectual property interests from a discovery or technology relating to health care.
Shibani S. Mukerji, MD, PhD Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.
Neel Mehta, Neel Mehta No disclosure on file
Tanuja Chitnis, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Moses Rodriguez, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Ildefonso Rodriguez-Leyva, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
Amy T. Waldman, MD Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has or had stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Calico. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care.
Alastair Compston, PhD, FRCP No disclosure on file
Jiwon Oh, MD, FÂ鶹´«Ã½Ó³»­ Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Stuart J. McCarter, MD The institution of Dr. McCarter has received research support from NIH. The institution of Dr. McCarter has received research support from American Academy of Sleep Medicine Foundation.
Celia Oreja Guevara Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for viatris. Celia Oreja Guevara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for biogen. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bms. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for jannsen.
André Luiz Guimarães de Queiroz André Luiz Guimarães de Queiroz has nothing to disclose.
Donna Gutterman Donna Gutterman has received personal compensation for serving as an employee of Zynerba Pharmaceuticals.
Amy Hellman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Hellman has received research support from COBRE-NIH. The institution of Dr. Hellman has received research support from Neurocrine.
Micah D. Yost, DO No disclosure on file
Laurent Vernillet No disclosure on file
Ines Gonzalez Suarez Ines Gonzalez Suarez has nothing to disclose.
Tomotaka Mizoguchi Tomotaka Mizoguchi has nothing to disclose.
Rafael Gemaque Lima Bentes Mr. Gemaque Lima Bentes has nothing to disclose.
Karlla Danielle Ferreira Lima Karlla Danielle Ferreira Lima has nothing to disclose.
Sandra M. Torres, Sr., MD No disclosure on file
William Souza Martins Ferreira Mr. Souza Martins Ferreira has nothing to disclose.
Laura Brennan No disclosure on file
Aubrey Adams, PhD Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Saugat Dey, MD No disclosure on file
Paul M. Katz, MD Dr. Katz has nothing to disclose.
Makoto Hara, MD Dr. Hara has nothing to disclose.
Dixon Yang, MD Dr. Yang has nothing to disclose.
Ruiqing Sun, MD, PhD Dr. Sun has nothing to disclose.
Stephen Greene Stephen Greene has received personal compensation for serving as an employee of SK Life Science, Inc.
Auli Verkkoniemi-Ahola No disclosure on file
Marie M. Moore, NP No disclosure on file
Rachel Brown, MD No disclosure on file
Yinka Read, PsyD No disclosure on file
Robert E. Shapiro, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Shapiro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Shapiro has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. Dr. Shapiro has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for EEOC.
William E. Rosenfeld, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Stefan Braune Stefan Braune has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTransData. Stefan Braune has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Stefan Braune has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroTransData.
Uday Murgod Uday Murgod has nothing to disclose.
Anna Khanna, MD Dr. Khanna has nothing to disclose.
Jonathan Ciron, MD Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS - Celgene. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Christos J. Petropoulos, PhD Dr. Petropoulos has received personal compensation for serving as an employee of Labcorp-Monogram Biosciences. Dr. Petropoulos has stock in Laboratory Corporation of America Holdings. Dr. Petropoulos has received intellectual property interests from a discovery or technology relating to health care.
Imran A. Waggan Dr. Waggan has nothing to disclose.
Karan Hingorani, MD, PhD Dr. Hingorani has nothing to disclose.
Arkady Nisman, PharmD Dr. Nisman has received personal compensation for serving as an employee of SK Life Science, Inc.. Dr. Nisman has a non-compensated relationship as a Senior Director, Medical Affairs with SK Life Science, Inc. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Ganesh Babulal, PhD, OTD, MSCI, MOT Ganesh Babulal, PhD, OTD, MSCI, MOT has nothing to disclose.
Maher Saqqur, MD Dr. Saqqur has nothing to disclose.
Wallace Brownlee, MD Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Hafsa Bareen Syeda, MBBS Dr. Syeda has nothing to disclose.
Corneliu C. Luca, MD Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Livia D. Sousa, MD Dr. Sousa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer,Merck,Novartis,Biogen,Saniofi,Roche.
Mariel Davila Martinez, MD Dr. Davila Martinez has nothing to disclose.
Amr H. Ewida, MD Dr. Ewida has nothing to disclose.
Raisa Saron W. Murari, MD No disclosure on file
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Tanya Stojkovic Tanya Stojkovic has nothing to disclose.
Stephen G. Vincent, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Nawaz Hack, MD Dr. Hack has nothing to disclose.
Yvonne Geissbuhler No disclosure on file
Naiade Couto, MD Dr. Couto has nothing to disclose.
Van Hellerslia, PharmD No disclosure on file
Michael Nahhas, MD Dr. Nahhas has nothing to disclose.
Dominique Mortel, MD Dr. Mortel has nothing to disclose.
Kelsey Christoffel, MD No disclosure on file
George Skulikidis, PA No disclosure on file
Michael Huebschen Michael Huebschen has received personal compensation for serving as an employee of Merck Healthcare Germany. Michael Huebschen has received personal compensation for serving as an employee of Esai Deutschland. Michael Huebschen has received personal compensation for serving as an employee of Eisai Schweiz GmbH. Michael Huebschen has received personal compensation for serving as an employee of Novartis Pharma Schweiz Ag. Michael Huebschen has stock in Merck. Michael Huebschen has stock in Sandoz. Michael Huebschen has stock in Novartis.
Joseph Sisti IV No disclosure on file
Henry P. Moore, MD Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Pamela A. McCombe, MD Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. The institution of Dr. McCombe has received research support from Motor Neurone Disease Resaerch Institute of Australia.
Anita Koshy, MD The institution of Dr. Koshy has received research support from NIH.
Aman Deep, MD Dr. Deep has nothing to disclose.
Luke Chung Luke Chung has received personal compensation for serving as an employee of Sanofi Genzyme. Luke Chung has received stock or an ownership interest from Sanofi Genzyme.
Diaa Hamouda No disclosure on file
Louis Ferrari Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Catherine Lomen-Hoerth, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Lomen-Hoerth has nothing to disclose.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Jessica Z. Lee No disclosure on file
Olwen Murphy, MD Dr. Murphy has nothing to disclose.
Biman K. Ray, MD Dr. Ray has nothing to disclose.
Christopher Chin, MD No disclosure on file
Giovanni Martino, PhD No disclosure on file
Enmanuel Perez, MD, PhD Dr. Perez has nothing to disclose.
Mar Tintoré, MD, PhD The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela bio. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel and UCB Biopharma. Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal: Experimental, Translational and Clinical. The institution of Mar Tintoré, MD, PhD has received research support from Fundació La Marató de TV3. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III.
Li Shen Loo No disclosure on file
Sonia Kaur Singh, MD Dr. Singh has nothing to disclose.
Mario Masellis, MD Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. The institution of Dr. Masellis has received research support from Canadian Institutes of Health Research. The institution of Dr. Masellis has received research support from Ontario Brain Institute. The institution of Dr. Masellis has received research support from Weston Brain Institute. The institution of Dr. Masellis has received research support from Washington University. The institution of Dr. Masellis has received research support from Alector. Dr. Masellis has received publishing royalties from a publication relating to health care.
Valerie E. Wojna, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wojna has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Puerto Rico Health Sciences Journal, University of Puerto Rico Medical Sciences Campus. The institution of Dr. Wojna has received research support from NIH.
Leanne Casaubon, MD No disclosure on file
Simon Duchesne, PhD Dr. Duchesne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Qynapse SAS. Dr. Duchesne has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Group. Dr. Duchesne has received stock or an ownership interest from Qynapse SAS. Dr. Duchesne has received intellectual property interests from a discovery or technology relating to health care.
Maher Fakhouri, MD Dr. Fakhouri has nothing to disclose.
Ian Miller, MD Dr. Miller has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Miller has stock in Marinus Pharmaceuticals.
Jose F. Tellez Zenteno, MD, PhD, FRCP No disclosure on file
Michael Doyle, MRCPI No disclosure on file
Chaitanya Amrutkar, MD No disclosure on file
Mahsa Sadeghi, MD Dr. Sadeghi has nothing to disclose.
Amy W. Laitinen, MD No disclosure on file
Harmehr Sekhon No disclosure on file
Benzion Blech, MD Dr. Blech has nothing to disclose.
Lisa Brooks Lisa Brooks has received personal compensation for serving as an employee of Nevro. Lisa Brooks has received stock or an ownership interest from Nevro.
Apameh Tarazi, MD No disclosure on file
Thomas R. Haven, PhD Dr. Haven has nothing to disclose.
Michael Waltz No disclosure on file
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Chiesi . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Biohaven Ltd. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Bright Minds Biosciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neuren Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Praxis Precision Medicines that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Shanghai Zhimeng Biopharma that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Supernus Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with UCB Biopharma SRL that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ultragenyx that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Stephanie J. Nahas, MD, FÂ鶹´«Ã½Ó³»­ Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AbbVie. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a expert for CME activities with Medscape/WebMD. Dr. Nahas has a non-compensated relationship as a Board Member-at-Large with American Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Nahas has a non-compensated relationship as a Executive Board Member with The Headache Alliance that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
John M. Bertoni, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bertoni has nothing to disclose.
Todd J. Schwedt, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Schwedt has or had stock in Nocira.Dr. Schwedt has or had stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. The institution of Dr. Schwedt has received research support from AbbVie. The institution of Dr. Schwedt has received research support from Flinn Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
George J. Hutton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.
Caroline L. Medeiros, Jr., MD Dr. Medeiros has nothing to disclose.
Antonio Culebras, MD, FAHA, FÂ鶹´«Ã½Ó³»­ Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received publishing royalties from a publication relating to health care. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a RESEARCH REVIEWER with DEPARTMENT OF DEFENSE. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a REVIEWER with DOD.
Guillaume Sebire No disclosure on file
Eliz H. Agopian, MD Dr. Agopian has nothing to disclose.
Arjun V. Masurkar, MD The institution of Dr. Masurkar has received research support from NIH. The institution of Dr. Masurkar has received research support from Alzheimer's Association. The institution of Dr. Masurkar has received research support from BrightFocus Foundation. Dr. Masurkar has received personal compensation in the range of $500-$4,999 for serving as a IRGP Advisory Council Member with Alzheimer's Association. Dr. Masurkar has a non-compensated relationship as a Steering Committee Member with Alzheimer's Disease Cooperative Study that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Disha Kohli, MD, MBBS Dr. Kohli has nothing to disclose.
Jan A. Hillert, MD Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Rashid A. Ahmed, MD Dr. Ahmed has nothing to disclose.
Victor Mantelatto Bonsi Victor Mantelatto Bonsi has nothing to disclose.
Nicholas J. Fleming, MD Dr. Fleming has nothing to disclose.
Ronak Patel, MBBS No disclosure on file
Ahmed Chenna, PhD Dr. Chenna has received personal compensation for serving as an employee of LabCorp-monogram Biosciences. Dr. Chenna has or had stock in LabCorp.
Maria A. Garcia-Dominguez, MD Dr. Garcia-Dominguez has received personal compensation for serving as an employee of Genentech.
Feza Deymeer, MD No disclosure on file
Jonathan Howard, MD Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Nusrat Ahsan, MD Dr. Ahsan has nothing to disclose.
Goutam Gangopadhyay No disclosure on file
Paul B. Hart Mr. Hart has nothing to disclose.
Diana Angelika Olszewska, MD, PhD Dr. Olszewska has nothing to disclose.
Johnathan L. McKay, PhD The institution of Dr. McKay has received research support from NIH. The institution of Dr. McKay has received research support from the McCamish Foundation.
Kevin Pacheco-Barrios, MD Dr. Pacheco-Barrios has nothing to disclose.
Faraze Niazi Ms. Niazi has nothing to disclose.
Anna Hauswirth, MD, PhD No disclosure on file
Wan Yee Kong, MBBS Dr. Kong has nothing to disclose.
John Markman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Markman has received personal compensation for serving as an employee of Eli LIlly.
Anantha Vellipuram, MD Dr. Vellipuram has nothing to disclose.
Joyce Y. Wu, MD Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus. The institution of Dr. Wu has received research support from National Institutes of Health. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health.
Stefan Blum, PhD, FRACP The institution of Dr. Blum has received research support from Merck. The institution of Dr. Blum has received research support from MSRA. The institution of Dr. Blum has received research support from PA Research Foundation.
Sidney Oparah, MD Dr. Oparah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis . Dr. Oparah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for MICRO LABS.
Fabien S. Bakdache, PharmD No disclosure on file
Aliyah J. Glover Miss Glover has nothing to disclose.
Brittany L. Poinson, MD Dr. Brand- Poinson has nothing to disclose.
Abigail M. Taylor, PA Ms. Taylor has nothing to disclose.
Bo C. Leung, MD Dr. Leung has nothing to disclose.
Caroline Dallaire-Théroux, MD, PhD Dr. Dallaire-Théroux has received research support from Canadian Institutes of Health Research (CIHR).
Jorge Maurino Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Omar Abdel-Mannan, MD Dr. Abdel-Mannan has nothing to disclose.
Lars Viktrup No disclosure on file
Maria Claudia Manieri No disclosure on file
Nathane B. Rezende, MD Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Aztrazeneca. Dr. Rezende has received research support from ECTRIMS.
Aaron S. Kemp, PhD Aaron Kemp has nothing to disclose.
Tran B. Le, MD Dr. Le has nothing to disclose.
Reuben Beer, MBBS Dr. Beer has nothing to disclose.
Jacob L. Van Orman, MD Dr. Van Orman has nothing to disclose.
Thomas A. Nelson, MD Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adya.
Bari Talente No disclosure on file
Ihtesham A. Qureshi, MD No disclosure on file
Steven C. Yang, DO Dr. Yang has nothing to disclose.
Muhammad Waleed Zeb, MD, MBBS No disclosure on file
Tsubasa Tomoto, PhD Dr. Tomoto has nothing to disclose.
Chindhuri Selvadurai Dr. Selvadurai has nothing to disclose.
Gaurav Singh, MBBS No disclosure on file
Javier Sotoca Fernandez Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Javier Sotoca Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Ozomma I. Simon, MBBS Dr. Simon has nothing to disclose.
Sabeena I. Malik, MD Dr. Malik has nothing to disclose.
Harathi Bandaru, MD Dr. Bandaru has nothing to disclose.
Rodrigo Q. Silveira, MD Dr. Silveira has nothing to disclose.
Rahim Shakoor, MD Dr. Shakoor has nothing to disclose.
Carolyn Goldschmidt, DO Dr. Goldschmidt has nothing to disclose.
Anita M. Fletcher, MD Dr. Fletcher has nothing to disclose.
Maya Hrachova, DO Dr. Hrachova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Therapeutics.
Alison Caruana, MD No disclosure on file
Erika Petersen, MD Erika Petersen, MD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Nevro. Erika Petersen, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott Neuromodulation. Erika Petersen, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Erika Petersen, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertos. Erika Petersen, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Saluda. Erika Petersen, MD has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Pain and Neurosciences. Erika Petersen, MD has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SynerFuse. Erika Petersen, MD has stock in SynerFuse. Erika Petersen, MD has stock in neuro.42. The institution of Erika Petersen, MD has received research support from Saluda. The institution of Erika Petersen, MD has received research support from Nevro. The institution of Erika Petersen, MD has received research support from ReNeuron. The institution of Erika Petersen, MD has received research support from Neuros. Erika Petersen, MD has received intellectual property interests from a discovery or technology relating to health care.
Kyle Edwards No disclosure on file
Cecilia Peterson An immediate family member of Ms. Peterson has received personal compensation for serving as an employee of 100Plus.
Moein Amin, MD Dr. Amin has nothing to disclose.
Halina Sienkiewicz-Jarosz, PhD Halina Sienkiewicz-Jarosz, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier. Halina Sienkiewicz-Jarosz, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Tribune. The institution of Halina Sienkiewicz-Jarosz, PhD has received research support from The National Centre for Research and Development.
Nabeela Nathoo, MD, PhD Dr. Nathoo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Kendall Wyllie, MD No disclosure on file
Joseph Conovaloff, MD No disclosure on file
Philip Yeung, MD Dr. Yeung has nothing to disclose.
Nicolae Done, PhD Dr. Done has received personal compensation for serving as an employee of Analysis Group, Inc.
Peter Bailey, MD No disclosure on file
Karissa Arca, MD The institution of Dr. Arca has received research support from Miles for Migraine. Dr. Arca has received personal compensation in the range of $0-$499 for serving as a speaker with Miles for Migraine.
Robert Kotloski, MD The institution of Dr. Kotloski has received research support from Department of Veterans Affairs.
Andrea I. Ciplea An immediate family member of Ms. Ciplea has received personal compensation for serving as an employee of Astra Zeneca. Ms. Ciplea has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Bayer Healthcare. Ms. Ciplea has received personal compensation in the range of $0-$499 for serving as a payment of travel-related expenses with Novartis. Ms. Ciplea has received personal compensation in the range of $0-$499 for serving as a payment of congress fees with Teva.
Joseph T Nguyen Joseph T Nguyen has nothing to disclose.
Arthur Ramalho Monfredinho, MD Dr. Ramalho Monfredinho has nothing to disclose.
Gregory S. Day, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with Â鶹´«Ã½Ó³»­. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Â鶹´«Ã½Ó³»­, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Jonathan Santoro, MD Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Umesh K. Sharma, MD Dr. Sharma has nothing to disclose.
Catherine M. Roe, PhD No disclosure on file
Owen A. Ross, PhD Dr. Ross has nothing to disclose.
Carlos A. Luciano, MD, FÂ鶹´«Ã½Ó³»­ Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SIMED. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Vazquez-Irizarry Law Office. The institution of Dr. Luciano has received research support from National Institutes of Health. Dr. Luciano has received personal compensation in the range of $100,000-$499,999 for serving as a Professor and Chair with University of Puerto Rico.
Lourdes Benes, MD, FÂ鶹´«Ã½Ó³»­ Dr. Benes has nothing to disclose.
Robert J. Giombetti, MD No disclosure on file
Meghana Raghavan, MBBS No disclosure on file
Souvik Dubey Souvik Dubey has nothing to disclose.
Kumaran Deiva No disclosure on file
Hannah George No disclosure on file
Miguel A. Santiago-Cruz No disclosure on file
Lizmarie Tirado-Castro No disclosure on file
Filipe Palavra No disclosure on file
Helene Verhelst No disclosure on file
Rahul Rao, MD Dr. Rao has nothing to disclose.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Charuta N. Joshi, MD No disclosure on file
Rosa Cortese No disclosure on file
Ina Mexhitaj, PhD No disclosure on file
Julie E. Demartino No disclosure on file
Rafael Brito No disclosure on file
Yolanda Aladro Yolanda Aladro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Almirall, Sanofi, Novartis, Bristoll. The institution of Yolanda Aladro has received research support from Roche, Almirall, Merck.
Rui Li Mr. Li has nothing to disclose.
Hannah Cock, MD No disclosure on file
Maria Diez-Cirarda No disclosure on file
Bastien Rioux, MD Dr. Rioux has nothing to disclose.
Matthew Burford, MD The institution of Dr. Burford has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Burford has received research support from Pharnext Inc.
Maria Siddiqi, MD Dr. Siddiqi has nothing to disclose.
Alex Gunko, MD No disclosure on file
Juan Pablo Pauta Martinez, MD Dr. Pauta Martinez has nothing to disclose.
Amir A. Mbonde, MD Dr. Mbonde has nothing to disclose.
Mohammad Rauf A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Michael A. Connerney, MD Dr. Connerney has nothing to disclose.
Ann C. Cabot, DO No disclosure on file
John R. Sollee Mr. Sollee has nothing to disclose.
Joshua D. Katz, MD The institution of Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Theraputics. The institution of Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen Pharmaceuticals. The institution of Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. The institution of Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi-Genzyme. The institution of Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono.
Thiago D. Pinheiro, MD Dr. Pinheiro has nothing to disclose.
Andrew T. Guidry, MD Dr. Guidry has received personal compensation in the range of $500-$4,999 for serving as a Ringside Physician with Maryland State Athletic Commission. Dr. Guidry has received personal compensation in the range of $500-$4,999 for serving as a Fact Witness with Legal Cases.
Alicia Henriquez, MD Dr. Henriquez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Italfarmaco. Dr. Henriquez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Henriquez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Henriquez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Henriquez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Henriquez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Daniel Garbin Di Luca, MD Dr. Garbin Di Luca has nothing to disclose.
Anna Vasilevskaya, PhD Anna Vasilevskaya has nothing to disclose.
Melissa Ng, MB BChir Dr. Ng has nothing to disclose.
Iwona Kurkowska-Jastrzebsk No disclosure on file
Maria Patricia Hernández Mitre, PhD No disclosure on file
Olivier Beauchet, MD, PhD No disclosure on file
Seyed Ali Naeimi, MD No disclosure on file